Position in ABBV
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$9,243,240
+$986,885 QoQ
Shares Held
36,732
-3.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.06%
of 13F equity value
Holder Rank
#966
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GREATMARK INVESTMENT PARTNERS, INC. holds $72,037,606 across 8 Drug Manufacturers - General names. ABBV ranks #3 (12.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
114,692 | $29,128,327 | |
| 2 | AMGN |
Amgen Inc
|
71,294 | $25,816,983 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
36,732 | $9,243,240 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
28,312 | $3,576,938 | |
| 5 | LLY |
ELI LILLY & Co
|
2,673 | $3,206,076 | |
| 6 | MRK |
Merck & Co., Inc.
|
3,806 | $489,071 | |
| 7 | AZN |
Astrazeneca PLC
|
1,821 | $345,298 | |
| 8 | PFE |
Pfizer Inc
|
9,621 | $231,673 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,243,240 | 36,732 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $8,256,355 | 37,962 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $8,840,735 | 38,692 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $9,219,922 | 39,820 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $7,630,838 | 41,110 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $8,648,985 | 41,280 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $7,321,240 | 41,200 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $7,803,422 | 39,515 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $6,810,201 | 39,705 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $7,276,716 | 39,960 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $6,342,922 | 40,930 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $6,283,326 | 42,153 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $5,699,483 | 42,303 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $7,128,301 | 44,728 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $7,514,541 | 46,498 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $6,543,140 | 48,753 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $7,496,416 | 48,945 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $8,100,312 | 49,968 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $6,782,592 | 50,093 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $5,541,066 | 51,368 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $5,942,097 | 52,753 | Shares | Sole | 2021-08-23 | |
| 2021-03-31 | $5,754,923 | 53,178 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $5,933,216 | 55,373 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $4,923,258 | 56,208 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $5,638,771 | 57,433 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $4,778,484 | 62,718 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||